|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Feb 2, 2021
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current assets | |||||||||
| Cash | |||||||||
| Deferred offering costs | |||||||||
| Prepaid expenses | |||||||||
| Total Current Assets | |||||||||
| Non-current prepaid expenses | |||||||||
| Marketable securities held in Trust Account | |||||||||
| TOTAL ASSETS | |||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||||
| Current liabilities | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Accrued expenses | |||||||||
| Accrued offering costs | |||||||||
| Income taxes payable | |||||||||
| Promissory note - related party | |||||||||
| Total Current Liabilities | |||||||||
| Warrant liabilities | |||||||||
| Deferred underwriting fee payable | |||||||||
| TOTAL LIABILITIES | |||||||||
| Class A common stock subject to possible redemption 21,999,960 shares at redemption value of $10.04 and $10.00 per share, respectively, at September 30, 2022 and December 31, 2021 | |||||||||
| Class A common stock subject to possible redemption | |||||||||
| Total class A common stock subject to possible redemption 21,999,960 shares at redemption value of $10.04 and $10.00 per share, respectively, at September 30, 2022 and December 31, 2021 | |||||||||
| Stockholders' Deficit | |||||||||
| Common stock | |||||||||
| Class A common stock | |||||||||
| Class A Common Stock Not Subject to Redemption | |||||||||
| Total class A common stock | |||||||||
| Class B common stock | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Class B common stock | |||||||||
| Total Stockholders' Deficit | |||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT |
Loading...
